{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:46:02Z","timestamp":1792201562094,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":268,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.clinsp.2025.100804","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:55:14Z","timestamp":1759996514000},"page":"100804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["From blue November to broader diagnosis: The Youden index to evaluate the performance of any diagnostic tests"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4110-1038","authenticated-orcid":false,"given":"Paulo Sergio Panse","family":"Silveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4362-1715","authenticated-orcid":false,"given":"Flavio Trigo","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6225-8985","authenticated-orcid":false,"given":"Joaquim Edson","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3357-8939","authenticated-orcid":false,"given":"Jose Oliveira","family":"Siqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinsp.2025.100804_bib0001","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.clinsp.2025.100804_bib0002","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/sim.6432","article-title":"Efficient statistical tests to compare Youden index: accounting for contingency correlation","volume":"34","author":"Chen","year":"2015","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100804_bib0003","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin."},{"issue":"5","key":"10.1016\/j.clinsp.2025.100804_bib0004","article-title":"Cancer of the prostate gland","volume":"24","author":"Swallow","year":"2006","journal-title":"Surgery"},{"key":"10.1016\/j.clinsp.2025.100804_bib0005","series-title":"EMNLP 2015 \u2012 6th International Workshop on Health Text Mining and Information Analysis, LOUHI 2015 \u2012 Proceedings of the Workshop","article-title":"On the Impact of Twitter-based Health Campaigns: a Cross-Country Analysis of Movember","author":"Prasetyo","year":"2015"},{"key":"10.1016\/j.clinsp.2025.100804_bib0006","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3332\/ecancer.2019.963","article-title":"The impact of cancer campaigns in Brazil: a Google Trends analysis","volume":"13","author":"Quintanilha","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.clinsp.2025.100804_bib0011","author":"Guimar\u00e3es"},{"key":"10.1016\/j.clinsp.2025.100804_bib0012","author":"Silva"},{"key":"10.1016\/j.clinsp.2025.100804_bib0013","author":"Brand\u00e3o"},{"issue":"5","key":"10.1016\/j.clinsp.2025.100804_bib0014","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0022-5347(17)38491-4","article-title":"Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate","volume":"145","author":"Oesterling","year":"1991","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100804_bib0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: screening, Diagnosis, and Local Treatment with Curative Intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100804_bib0016","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer \u2012 2020 Update. Part 1: screening, Diagnosis, and Local Treatment with Curative Intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.clinsp.2025.100804_bib0017","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/bju.12318","article-title":"American urological association (AUA) guideline on prostate cancer detection: process and rationale","volume":"112","author":"Carter","year":"2013","journal-title":"BJU Int"},{"issue":"10","key":"10.1016\/j.clinsp.2025.100804_bib0018","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/iju.14039","article-title":"Screening for prostate cancer: history, evidence, controversies and future perspectives toward individualized screening","volume":"26","author":"Ito","year":"2019","journal-title":"Int J Urol"},{"issue":"7","key":"10.1016\/j.clinsp.2025.100804_bib0019","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.3758\/s13428-022-01950-0","article-title":"Better to be in agreement than in bad company: a critical analysis of many kappa-like tests","volume":"55","author":"Silveira","year":"2023","journal-title":"Behav Res Methods"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100804_bib0020","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/biostatistics\/kxr008","article-title":"Assessing the dependence of sensitivity and specificity on prevalence in meta-analysis","volume":"12","author":"Li","year":"2011","journal-title":"Biostatistics"},{"issue":"7","key":"10.1016\/j.clinsp.2025.100804_bib0021","article-title":"HIV-1 infection among crack cocaine users in a region far from the epicenter of the HIV epidemic in Brazil: prevalence and molecular characteristics","volume":"13","author":"Da Silva Fran\u00e7a","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.clinsp.2025.100804_bib0022","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1471-2458-10-317","article-title":"HIV prevalence among female sex workers, drug users and men who have sex with men in Brazil: a Systematic Review and Meta-analysis","volume":"10","author":"Malta","year":"2010","journal-title":"BMC Public Health"},{"issue":"7","key":"10.1016\/j.clinsp.2025.100804_bib0023","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1473-3099(12)70066-X","article-title":"Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis","volume":"12","author":"Baral","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"13","key":"10.1016\/j.clinsp.2025.100804_bib0024","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1503\/cmaj.060955","article-title":"Prostate-specific antigen in the early detection of prostate cancer","volume":"176","author":"Thompson","year":"2007","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100804_bib0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/13685538.2019.1578741","article-title":"Is prostate volume better than PSA density and free\/total PSA ratio in predicting prostate cancer in patients with PSA 2.5\u201310 ng\/mL and 10.1\u201330 ng\/mL?","volume":"23","author":"Erdogan","year":"2020","journal-title":"Aging Male"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100804_bib0026","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1464-410x.1998.00616.x","article-title":"Free-to-total prostate-specific antigen (PSA) ratio improves the specificity for detecting prostate cancer in patients with prostatism and intermediate PSA levels","volume":"81","author":"Recker","year":"1998","journal-title":"Br J Urol"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100804_bib0027","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.juro.2007.11.038","article-title":"PCA3: a molecular urine assay for predicting prostate biopsy outcome","volume":"179","author":"Deras","year":"2008","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.clinsp.2025.100804_bib0028","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.urolonc.2012.05.002","article-title":"PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and\/or suspicious digital rectal examination. First Latin American experience","volume":"31","author":"Ramos","year":"2013","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100804_bib0029","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.juro.2014.01.014","article-title":"Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study","volume":"192","author":"Thompson","year":"2014","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100804_bib0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5001\/omj.2017.55","article-title":"Validity of prostate health index and percentage of [-2] pro-prostate-specific antigen as novel biomarkers in the diagnosis of prostate cancer: omani tertiary hospitals experience","volume":"32","author":"Al Saidi","year":"2017","journal-title":"Oman Med J"},{"issue":"5","key":"10.1016\/j.clinsp.2025.100804_bib0031","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.eururo.2016.04.012","article-title":"Detection of high-grade prostate cancer using a urinary molecular biomarker\u2013based risk score","volume":"70","author":"Van Neste","year":"2016","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100804_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285745","article-title":"A meta-analysis for the diagnostic accuracy of SelectMDx in prostate cancer","volume":"19","author":"Wu","year":"2024","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.clinsp.2025.100804_bib0033","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.eururo.2014.10.021","article-title":"A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer","volume":"68","author":"Parekh","year":"2015","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.clinsp.2025.100804_bib0034","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1111\/cts.13372","article-title":"Liquid biopsy-based targeted gene screening highlights tumor cell subtypes in patients with advanced prostate cancer","volume":"15","author":"Derderian","year":"2022","journal-title":"Clin Transl Sci."},{"issue":"1","key":"10.1016\/j.clinsp.2025.100804_bib0035","doi-asserted-by":"crossref","DOI":"10.23937\/2469-5831\/1510026","article-title":"The basic four measures and their derivates in dichotomous diagnostic tests","volume":"6","author":"Tadeusz","year":"2020","journal-title":"Int J Clin Biostatistics Biometrics"},{"key":"10.1016\/j.clinsp.2025.100804_bib0036","doi-asserted-by":"crossref","unstructured":"Haimes Y.Y. Risk modeling, assessment, and management, Third Edition 2008.","DOI":"10.1002\/9780470422489"},{"issue":"11","key":"10.1016\/j.clinsp.2025.100804_bib0037","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.ejca.2010.03.040","article-title":"Prostate cancer: trends in incidence, survival and mortality in the Netherlands, 1989-2006","volume":"46","author":"Cremers","year":"2010","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100804_bib0038","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0022-5347(01)64231-9","article-title":"Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994","volume":"158","author":"Newcomer","year":"1997","journal-title":"J Urol"},{"issue":"17","key":"10.1016\/j.clinsp.2025.100804_bib0039","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1016\/j.ejca.2010.09.013","article-title":"Prostate cancer incidence and mortality trends in 37 European countries: an overview","volume":"46","author":"Bray","year":"2010","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.clinsp.2025.100804_bib0040","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0959-8049(97)10154-X","article-title":"Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in southeastern Netherlands 1971-1995","volume":"34","author":"Post","year":"1998","journal-title":"Eur J Cancer"},{"issue":"45","key":"10.1016\/j.clinsp.2025.100804_bib0041","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/jncimonographs\/lgs035","article-title":"Trends in prostate cancer in the United States","volume":"2012","author":"Brawley","year":"2012","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"3","key":"10.1016\/j.clinsp.2025.100804_bib0042","doi-asserted-by":"crossref","DOI":"10.1590\/s1677-5538.ibju.2018.0179","article-title":"A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice?","volume":"45","author":"Ara\u00fajo","year":"2019","journal-title":"International Braz J Urol"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100804_bib0043","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41391-020-0227-1","article-title":"Shared decision making, and prostate-specific antigen based prostate cancer screening following the 2018 update of USPSTF screening guideline","volume":"24","author":"Jiang","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"6","key":"10.1016\/j.clinsp.2025.100804_bib0044","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1590\/s1677-5538.ibju.2015.0690","article-title":"Prostate cancer in Brazil and Latin America: epidemiology and screening","volume":"42","author":"Tourinho-Barbosa","year":"2016","journal-title":"Int Braz J Urol"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100804_bib0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.14744\/SEMB.2023.77910","article-title":"State-of-the-art Prostate Imaging","volume":"57","author":"Ayyildiz","year":"2023","journal-title":"SiSli Etfal Hastanesi Tip Bul"},{"issue":"6","key":"10.1016\/j.clinsp.2025.100804_bib0046","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2021.07.024","article-title":"Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: european association of urology position and recommendations for 2021","volume":"80","author":"Van Poppel","year":"2021","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100804_bib0047","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive services task force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100804_bib0048","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JU.0000000000003491","article-title":"Early detection of prostate cancer: AUA\/SUO guideline Part I: prostate cancer screening","volume":"210","author":"Wei","year":"2023","journal-title":"J Urol."},{"issue":"3","key":"10.1016\/j.clinsp.2025.100804_bib0049","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11934-010-0109-5","article-title":"Prostate cancer screening: what we have learned from the PLCO and ERSPC trials","volume":"11","author":"La Rochelle","year":"2010","journal-title":"Curr Urol Rep"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100804_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281153","article-title":"Estimating the lifetime risk of a false positive screening test result","volume":"18","author":"White","year":"2023","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.clinsp.2025.100804_bib0051","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41568-019-0142-8","article-title":"Cancer overdiagnosis: a biological challenge and clinical dilemma","volume":"19","author":"Srivastava","year":"2019","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"10.1016\/j.clinsp.2025.100804_bib0052","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1038\/s41591-021-01595-0","article-title":"Underdiagnosis bias of artificial intelligence algorithms applied to chest radiographs in under-served patient populations","volume":"27","author":"Seyyed-Kalantari","year":"2021","journal-title":"Nat Med."},{"key":"10.1016\/j.clinsp.2025.100804_bib0053","first-page":"1","article-title":"Ethical considerations and implications of multi-cancer early detection screening: reliability, access and cost to test and treat","author":"Sempere","year":"2025","journal-title":"Camb Q Healthc Ethics"},{"key":"10.1016\/j.clinsp.2025.100804_bib0054","author":"Warner"},{"issue":"8","key":"10.1016\/j.clinsp.2025.100804_bib0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2019.0763","article-title":"Decision Aids for prostate cancer screening choice","volume":"179","author":"Riikonen","year":"2019","journal-title":"JAMA Intern Med"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593225002224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593225002224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:46:03Z","timestamp":1790711163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593225002224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":51,"alternative-id":["S1807593225002224"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2025.100804","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From blue November to broader diagnosis: The Youden index to evaluate the performance of any diagnostic tests","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2025.100804","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100804"}}